Latest Breaking News On - Deficiency associated lung disease - Page 3 : comparemela.com

LONDON, May 23, 2023 (GLOBE NEWSWIRE) Mereo BioPharma Group plc (NASDAQ: MREO), (“Mereo” or “the Company”), a clinical-stage biopharmaceutical company.

City ofUnited kingdomUnited statesRobert stockleyDenise scots knightChristine foxLee rothMereo biopharmaJackie parkinExchange commissionUnited states securities exchangeAmerican thoracic society international conferenceUltragenyx pharmaceutical incMereo biopharma groupUniversity of birmingham united kingdomSafety data monitoring committee